Matinas BioPharma
MTNB
$0.16
Share price
-5.42%
Change (1 day)
-56.86%
Change (1 year)
Categories
EPS for Matinas BioPharma (MTNB)
EPS in 2023 (TTM): -$0.11
According to Matinas BioPharma's latest financial reports the company's current EPS (TTM) is -$0.11. In 2022 the company made an earnings per share (EPS) of -$0.11 a decrease over its 2021 EPS that were of -$0.11.
EPS history for Matinas BioPharma from 2013 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$0.11 | -0% |
| 2022 | -$0.11 | -0% |
| 2021 | -$0.11 | -8.33% |
| 2020 | -$0.12 | -14.29% |
| 2019 | -$0.14 | -6.67% |
| 2018 | -$0.15 | -59.46% |
| 2017 | -$0.37 | 76.19% |
| 2016 | -$0.21 | 10.53% |
| 2015 | -$0.19 | -41.11% |
| 2014 | -$0.32 | 178.06% |
| 2013 | -$0.12 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | -$2.18 | 1,881.82% | 🇺🇸 USA |